Bethesda, MD, United States of America

Xue F Pei


Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 12(Granted Patents)


Location History:

  • Bethesda, MD (US) (1995)
  • Washington, DC (US) (1996)

Company Filing History:


Years Active: 1995-1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Xue F Pei

Introduction

Xue F Pei is a notable inventor based in Bethesda, MD, who has made significant contributions to the field of cognitive therapy and pharmaceutical chemistry. With a total of two patents to his name, his work focuses on innovative methods for treating cognitive disorders and the synthesis of important chemical compounds.

Latest Patents

Xue F Pei's latest patents include a method for the resolution and reduction of physostigmine intermediates and derivatives. This invention provides a means for separating racemic mixtures or mixtures enriched with specific enantiomers, which are crucial for developing effective pharmaceutical agents. Another significant patent involves a method for treating cognitive disorders with phenserine. This improved cholinomimetic therapy targets cognitive impairments associated with aging and Alzheimer's disease, offering hope for effective treatment options.

Career Highlights

Throughout his career, Xue F Pei has worked with esteemed organizations, including the United States of America as represented by the Secretary of Health and the Department of Health. His contributions have been instrumental in advancing therapeutic methods and chemical processes that benefit patients suffering from cognitive disorders.

Collaborations

Xue F Pei has collaborated with notable professionals in his field, including Arnold Brossi and Nigel H Greig. These partnerships have fostered innovation and have been pivotal in the development of his patented methods.

Conclusion

Xue F Pei's work exemplifies the intersection of innovation and healthcare, particularly in the treatment of cognitive disorders. His patents reflect a commitment to improving patient outcomes through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…